Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Vicriviroc |
Synonyms | |
Therapy Description |
Vicriviroc (MK-7690) is a CCR5 antagonist, which potentially decreases tumor cell invasiveness and metastasis (PMID: 22637726). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Vicriviroc | MK-7690|SCH 417690|SCH-417690 | Vicriviroc (MK-7690) is a CCR5 antagonist, which potentially decreases tumor cell invasiveness and metastasis (PMID: 22637726). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|